Table 2. Associations among E-cadherin, β-catenin and ALCAM expression in oral lesions and OSCCs.
Oral Lesions | pvalue | OR | 95% C.I. |
E-cad−/β-cat M- | 0.001 | 16.7 | 5.3–52.7 |
β-cat M−/ALCAM+ | 0.018 | 3.3 | 1.2–8.8 |
β-cat M−/ALCAM C+ | 0.008 | 3.6 | 1.4–9.3 |
OSCCs | |||
E-cad−/β-cat M- | 0.001 | 8.8 | 3.6–21.7 |
E-cad−/ALCAM C+ | 0.038 | 2.2 | 1.0–5.0 |
β-cat M−/ALCAM+ | 0.001 | 3.9 | 1.7–9.0 |
β-cat M−/ALCAM C+ | 0.002 | 3.7 | 1.6–8.7 |
E-cad-β-cat M−/ALCAM+ | 0.002 | 3.6 | 1.6–8.4 |
E-cad-β-cat M−/ALCAM C+ | 0.006 | 3.2 | 1.4–7.1 |